Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Nov;14(3):281-91.
doi: 10.1177/1087054709356388. Epub 2010 Mar 12.

A Compound Herbal Preparation (CHP) in the Treatment of Children With ADHD: A Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

A Compound Herbal Preparation (CHP) in the Treatment of Children With ADHD: A Randomized Controlled Trial

M Katz et al. J Atten Disord. .

Abstract

Objective: Evaluation of the efficacy of a patented, compound herbal preparation (CHP) in improving attention, cognition, and impulse control in children with ADHD.

Design: A randomized, double-blind, placebo-controlled trial.

Setting: University-affiliated tertiary medical center.

Participants: 120 children newly diagnosed with ADHD, meeting DSM-IV criteria.

Intervention: Random assignment to the herbal treatment group (n = 80) or control group (placebo; n = 40); 73 patients in the treatment group (91%) and 19 in the control group (48%) completed the 4-month trial.

Outcome measure: Test of Variables of Attention (TOVA) administered before and after the treatment period; overall score and 4 subscales.

Results: The treatment group showed substantial, statistically significant improvement in the 4 subscales and overall TOVA scores, compared with no improvement in the control group, which persisted in an intention-to-treat analysis.

Conclusions: The well-tolerated CHP demonstrated improved attention, cognition, and impulse control in the intervention group, indicating promise for ADHD treatment in children.

Similar articles

See all similar articles

Cited by 4 articles

Publication types

LinkOut - more resources

Feedback